News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
55,328 Results
Type
Article (1722)
Company Profile (14)
Press Release (53592)
Section
Business (23262)
Career Advice (80)
Deals (3392)
Drug Delivery (5)
Drug Development (4796)
Employer Resources (3)
FDA (936)
Job Trends (1434)
News (31361)
Policy (1540)
Tag
Academia (156)
Accelerated approval (3)
Allergies (7)
Alliances (2578)
ALS (3)
Alzheimer's disease (84)
Antibody-drug conjugate (ADC) (21)
Approvals (978)
Artificial intelligence (15)
Autoimmune disease (7)
Bankruptcy (17)
Best Places to Work (1244)
Biosimilars (18)
Biotechnology (10)
Bladder cancer (5)
Brain cancer (6)
Breast cancer (33)
Cancer (311)
Cardiovascular disease (34)
Career advice (66)
CAR-T (6)
CDC (1)
Cell therapy (27)
Cervical cancer (1)
Clinical research (4288)
Collaboration (80)
Compensation (21)
Complete response letters (2)
COVID-19 (104)
CRISPR (9)
C-suite (14)
Cystic fibrosis (10)
Data (543)
Depression (4)
Diabetes (40)
Diagnostics (580)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (8)
Drug pricing (11)
Duchenne muscular dystrophy (19)
Earnings (19871)
Editorial (2)
Employer resources (3)
Events (9291)
Executive appointments (24)
FDA (1235)
Fibrodysplasia Ossificans Progressiva (1)
Funding (66)
Gene editing (17)
Gene therapy (36)
GLP-1 (41)
Government (178)
Grass and pollen (1)
Guidances (174)
Healthcare (1607)
HIV (9)
Huntington's disease (16)
IgA nephropathy (4)
Immunology and inflammation (20)
Immuno-oncology (3)
Indications (12)
Infectious disease (131)
Inflammatory bowel disease (12)
Influenza (8)
Intellectual property (8)
Interviews (8)
IPO (2285)
IRA (2)
Job creations (266)
Job search strategy (63)
JPM (5)
Labor market (10)
Layoffs (31)
Legal (268)
Liver cancer (5)
Lung cancer (51)
Lymphoma (40)
Management (1)
Manufacturing (27)
MASH (10)
Medical device (1550)
Medtech (1556)
Mergers & acquisitions (1156)
Metabolic disorders (73)
mRNA (9)
Multiple sclerosis (15)
NASH (2)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (181)
NextGen: Class of 2026 (373)
Non-profit (267)
Now hiring (3)
Obesity (24)
Opinion (5)
Ovarian cancer (15)
Pain (14)
Pancreatic cancer (9)
Parkinson's disease (13)
Partnered (1)
Patents (7)
Patient recruitment (13)
Peanut (1)
People (2134)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase 1 (1098)
Phase 2 (1702)
Phase 3 (1797)
Pipeline (886)
Policy (6)
Postmarket research (186)
Preclinical (475)
Press Release (7)
Prostate cancer (8)
Radiopharmaceuticals (10)
Rare diseases (45)
Real estate (349)
Recruiting (1)
Regulatory (1301)
Reports (7)
Research institute (144)
Resumes & cover letters (11)
Rett syndrome (1)
RSV (13)
Schizophrenia (27)
Series A (8)
Series B (18)
Sickle cell disease (6)
Special edition (3)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (137)
Supply chain (4)
Tariffs (3)
The Weekly (3)
Vaccines (46)
Venture capital (4)
Weight loss (17)
Women's health (2)
Date
Today (16)
Last 7 days (62)
Last 30 days (215)
Last 365 days (2813)
2026 (332)
2025 (2803)
2024 (3445)
2023 (3895)
2022 (4453)
2021 (5139)
2020 (4622)
2019 (3842)
2018 (2726)
2017 (1963)
2016 (1414)
2015 (1884)
2014 (1368)
2013 (931)
2012 (1159)
2011 (6715)
2010 (1189)
Location
Africa (31)
Alabama (4)
Arizona (25)
Asia (2596)
Australia (339)
California (1157)
Canada (295)
China (75)
Colorado (54)
Connecticut (87)
Delaware (32)
Europe (6644)
Florida (135)
Georgia (24)
Idaho (2)
Illinois (115)
India (4)
Indiana (66)
Japan (25)
Kansas (58)
Kentucky (4)
Louisiana (7)
Maine (9)
Maryland (124)
Massachusetts (611)
Michigan (30)
Minnesota (65)
Missouri (13)
Montana (4)
Nebraska (1)
Nevada (2)
New Hampshire (5)
New Jersey (469)
New York (191)
North Carolina (144)
Northern California (595)
Ohio (23)
Oregon (1)
Pennsylvania (190)
South America (69)
South Carolina (2)
Southern California (471)
Tennessee (16)
Texas (151)
United States (3861)
Utah (30)
Virginia (15)
Washington D.C. (4)
Washington State (88)
Wisconsin (5)
55,328 Results for "130".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Angitia Biopharmaceuticals Announces $130 Million Series D Financing
February 5, 2026
·
4 min read
Press Releases
Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders
February 24, 2026
·
4 min read
Press Releases
Theranica Announces U.S. Coverage for Nerivio® Reaching ~130 Million Lives, Attaining Payer Scale Comparable to Leading Migraine Drugs
February 5, 2026
·
3 min read
Press Releases
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
January 8, 2026
·
5 min read
Series B
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.
December 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
·
5 min read
Press Releases
QUVIVIQ sales up >130% driving Idorsia toward profitability – 9M 2025 results
October 30, 2025
·
12 min read
Press Releases
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
October 15, 2025
·
9 min read
Press Releases
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants
October 30, 2025
·
5 min read
Press Releases
Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study
December 2, 2025
·
3 min read
1 of 5,533
Next
